ENGLEWOOD, Colo., July 12, 2023 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced preliminary results…
Weight-loss drugs are increasingly popular among employees but weigh heavily on health-insurance budgets. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
The organization plans to hire up to four more people this year. Click here to view original post
I was living on the precipice of end-stage disease when I enrolled in the clinical trial that resulted in the historically fast Food and Drug Administration approval for the game-changing cystic fibrosis drug Trikafta. Five […]
Copyright © 2026 Biotech Networks
